Cargando…

Rational Use of Tocilizumab in the Treatment of Novel Coronavirus Pneumonia

Since December 2019, a novel coronavirus pneumonia (COVID-19) has broken out in Wuhan, China and spread rapidly. Recent studies have found that ⁓ 15.7% of patients develop severe pneumonia, and cytokine storm is an important factor leading to rapid disease progression. Currently, there are no specif...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Shengyu, Li, Lei, Shen, Aizong, Chen, Yongwu, Qi, Zhigang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7183818/
https://www.ncbi.nlm.nih.gov/pubmed/32337664
http://dx.doi.org/10.1007/s40261-020-00917-3